Clinical Trials Directory

Trials / Completed

CompletedNCT04789447

Initial CT Findings and CO-RADS Stage in COVID-19

Comparison of Initial CT Findings and CO-RADS Stage in COVID-19 Patients With PCR, Inflammation and Coagulation Parameters in Diagnostic and Prognostic Perspectives

Status
Completed
Phase
Study type
Observational
Enrollment
895 (actual)
Sponsor
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to determine whether patients with different real-time reverse transcriptase-polymerase chain reaction (PCR), chest computed tomography (CT) and laboratory findings have different clinical outcomes.

Detailed description

This study aims to determine the rates of PCR positivity and CT findings in hospitalized patients with a diagnosis of COVID-19, to determine whether there is a difference in mortality and need for ICU between patients grouped according to the PCR positivity and presence of CT findings, and to evaluate the effect of the CO-RADS stage on these outcomes. Moreover, it is to compare the effects of inflammation and coagulation markers and CO-RADS stage on the severity of the disease

Conditions

Timeline

Start date
2021-03-04
Primary completion
2021-05-06
Completion
2021-05-06
First posted
2021-03-09
Last updated
2021-06-09

Locations

2 sites across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04789447. Inclusion in this directory is not an endorsement.